MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Correlation between hemoglobin level and disease severity in patients with Parkinson’s disease

    O. Gavriliuc, L. Rotaru, M. Gavriliuc, A. Caldarov (Chisinau, Republic of Moldova)

    Objective: Objective of this study was to investigate the potential correlation between hemoglobin levels and Parkinson's disease (PD) severity, and to compare them with a…
  • 2023 International Congress

    Clinical spectrum, imaging characteristics and care giver burden assessment of early onset non-dominant progressive cerebellar ataxias

    R. Devaraj, P. Pal, N. M, RY. Yadav, M. Faruq, J. Saini, S. Hegde (Bangalore, India)

    Objective: To characterise the phenotypic and radiological spectrum of patients with early onset non-dominant progressive cerebellar ataxias and to assess the impact of the disease…
  • 2023 International Congress

    Musical Perception in Parkinson’s Disease, a Pilot Study

    K. Vourou (Athens, Greece)

    Objective: This pilot study aimed to investigate whether patients with PD have deficits in the perception of melody, rhythm, and musical excerpt recognition as measured…
  • 2023 International Congress

    The role of the default mode network and striatal circuits in the expression of depressive symptoms in premanifest Huntington’s disease

    T. Barta, L. Novelli, N. Georgiou-Karistianis, J. Stout, S. Loi, Y. Glikmann-Johnston, A. Razi (Clayton, Australia)

    Objective: This study aimed to investigate changes in large-scale network effective connectivity of the default mode network (DMN) and striatum in the expression of depression…
  • 2023 International Congress

    Integrative analysis of fecal metabolomics and metagenomics for Parkinson’s disease

    Y. Qian, S. Xu, X. He, Y. Lai, Y. Zhang, C. Mo, P. Ai, X. Yang, Q. Xiao (Shanghai, China)

    Objective: The objectives of the current study were to explore how the fecal metabolomics changed, and how they interacted with the alteration of microbiota in…
  • 2023 International Congress

    Apathy and impulsivity co-occur in Huntington’s disease

    L. Morris, K. Horne, L. Paermentier, C. Buchanan, M. Macaskill, D. Myall, M. Husain, R. Roxburgh, T. Anderson, C. Le Heron (Christchurch, New Zealand)

    Objective: To determine whether apathy and impulsivity co-occur in people with Huntington’s disease. Background: Apathy and impulsivity are debilitating behavioural changes which often occur in…
  • 2023 International Congress

    Automated VMAT2 [18F]AV-133 PET analysis in Parkinson’s disease

    R. Manber, B. Brito Vega, C. Mcginnity (London, United Kingdom)

    Objective: To evaluate a fully automated image analysis pipeline to process vesicular monoamine transporters type 2 (VMAT2) [18F]AV-133 tracer positron emission tomography (PET) images, by…
  • 2023 International Congress

    Hemi-dystonia secondary to encephalitis and its response to staged pallidotomy

    S. Yadav, A. Das, A. Srivastava (Delhi, India)

    Objective: Reporting a case of hemi-dystonia (with involvement of trunk) secondary to encephalitis and its response to staged bilateral pallidotomy. Background: In the Axis 1…
  • 2023 International Congress

    Measuring the heterogeneity of disease progression in Parkinson’s disease with multimodal clinical milestones over 10 years in the DeNoPa cohort

    S. Weber, M. Dakna, A. Bednorz, M. Bartl, E. Lang, T. Wicke, M. Starke, J. Ebentheuer, F. Sixel-Döring, M. Muntean, S. Schade, C. Trenkwalder, B. Mollenhauer (Goettingen, Germany)

    Objective: To provide a reference of individual Parkinson’s disease (PD) progression by assessing multimodal milestones over 10 years (y) in patients of the DeNoPa cohort.…
  • 2023 International Congress

    Premenstrual worsening of UPDRS motor scale in women affected by Parkinson’s Disease

    A. Thomas, D. Calisi, M. de Rosa, P. Ajdinaj, S. Sensi, M. Onodrj (Chieti, Italy)

    Objective: The role of estrogen in dopaminergic pathways and the premenstrual worsening of parkinsonian symptoms. Background: Female sex hormones, during the menstrual cycle, could influence…
  • « Previous Page
  • 1
  • …
  • 49
  • 50
  • 51
  • 52
  • 53
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley